NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE

NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE

Show other versions (1)

<p><em>The article describes advantages of new combined drug Foster — formoterol (6 ?g) and beclometasone) (100 ?g) in treatment of patients with bronchial asthma. It was marked that the drug is based on original delivery technology «Modulite» allowing creation an aerosol with extra fine...

Full description

Bibliographic Details
Main Author:	O.I. Simonova
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2010-01-01
Series:	Вопросы современной педиатрии
Online Access:	http://vsp.spr-journal.ru:80/jour/article/view/905

Similar Items

NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
by: O.I. Simonova
Published: (2010-05-01)

High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma
by: Massimo Corradi, et al.
Published: (2016-10-01)

Мometasone furoate/formoterol: new fixed-dose combination in the treatment of bronchial asthma
by: A. V. Еmelyanov
Published: (2013-12-01)

Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthma
by: Piotr Kuna, et al.
Published: (2022-08-01)

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01)

EFFICACY AND SAFETY OF FORMOTEROL IN CHILDREN WITH BRONCHIAL ASTHMA EXACERBATIONS
by: S.V. Zaitseva, et al.
Published: (2008-01-01)

EFFICACY AND SAFETY OF FORMOTEROL IN CHILDREN WITH BRONCHIAL ASTHMA EXACERBATIONS
by: S.V. Zaitseva, et al.
Published: (2008-10-01)

Efficacy and safety of mometasone furoate/formoterol combination in patients with bronchial asthma
by: A. V. Emelyanov
Published: (2015-12-01)

Penggunaan Extrafine Beclometason Diproprionat/Formoterol Fumarat pada PPOK [Combined Extrafine Beclomethason Diproprionat/Formoteral Fumarat in COPD]
by: Sakinatus Syarifah, et al.
Published: (2019-05-01)

TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life
by: Richeldi L, et al.
Published: (2024-02-01)

THE VALUE OF THE COMPOUND DRUGS FORMOTEROL AND IPRATROPIUM BROMIDE IN COMPLEX TREATMENT OF CHRONIC NONSPECIFIC LUNG DISEASES IN CHILDREN
by: O.I. Simonova
Published: (2006-01-01)

THE VALUE OF THE COMPOUND DRUGS FORMOTEROL AND IPRATROPIUM BROMIDE IN COMPLEX TREATMENT OF CHRONIC NONSPECIFIC LUNG DISEASES IN CHILDREN
by: O.I. Simonova
Published: (2006-03-01)

Extrafine Beclometasone Dipropionate/Formoterol NEXThaler on Device Usability, Adherence, Asthma Control and Quality of Life. A Panhellenic Prospective, Non-Interventional Observational Study in Patients with Asthma—The NEXT-Step Study
by: Petros Bakakos, et al.
Published: (2022-01-01)

The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD
by: James Dean, et al.
Published: (2020-12-01)

The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study Protocol
by: Richeldi L, et al.
Published: (2021-01-01)

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.
by: Pavord, I, et al.
Published: (2009)

Fixed-dose combination fluticasone/formoterol for asthma treatment in a real-world setting: meta-analysis of exacerbation rates and asthma control
by: Alberto Papi, et al.
Published: (2023-01-01)

The effect of inhaled extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide on distal and central airway indices, assessed using Functional Respiratory Imaging in COPD (DARWiIN)
by: Gwen S. Skloot, et al.
Published: (2023-10-01)

Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform®) for the treatment of asthma
by: Tan RA, et al.
Published: (2014-09-01)

Clinic and treatment of bronchial asthma, combined with cardiovascularpathology
by: N. V. Gordeyeva, et al.
Published: (2007-06-01)

THE SAFETY PROFILE OF INHALED CORTICOSTEROIDS (BECLOMETASONE DIPROPIONATE) APPLIED IN CONVENTIONAL AND HIGH DOSES IN THE PREVENTION OF CHILDHOOD ASTHMA
by: Milica Martinovic
Published: (2008-01-01)

Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation
by: Sergey K. Zyryanov, et al.
Published: (2022-08-01)

Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial
by: O'Connor Brian J, et al.
Published: (2011-12-01)

Modern understanding of bronchial asthma with fixed airflow obstruction
by: Angelina Yu. Kraposhina, et al.
Published: (2021-03-01)

Controlled trial of budesonide–formoterol as needed for mild asthma
by: Beasley, R, et al.
Published: (2019)

Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
by: Moitra S, et al.
Published: (2015-04-01)

9&#945;-Bromo analog of beclometasone dipropionate monohydrate
by: Kamal Aziz Ketuly, et al.
Published: (2009-08-01)

Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma
by: Fang Yi, et al.
Published: (2022-10-01)

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01)

Bronchial thermoplasty for the treatment of asthma.
by: Martin, N, et al.
Published: (2009)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
by: Hyun-moon Back, et al.
Published: (2020-04-01)

Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma
by: Pearlman David, et al.
Published: (2011-11-01)

Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
by: Taisuke Akamatsu, et al.
Published: (2012-01-01)

Asthma Control Can Be Maintained after Fixed-Dose, Budesonide/Formoterol Combination Inhaler Therapy is Stepped Down from Medium to Low Dose
by: Masayuki Hojo, et al.
Published: (2013-01-01)

Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma
by: Prosser TR, et al.
Published: (2015-06-01)

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone
by: Price DB, et al.
Published: (2022-02-01)

The modern view of treatment of allergic rhinitis and it’s combination with bronchial asthma
by: D. S. Smirnov, et al.
Published: (2021-05-01)

Analysis of the list of dugs for the treatment of bronchial asthma in children acording to state form
by: K. L. Kosyachenko, et al.
Published: (2019-03-01)

Ciclesonide in the treatment of patients with bronchial asthma
by: V. I. Trofimov
Published: (2014-12-01)

Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base
by: Anthony D. D’Urzo, et al.
Published: (2019-05-01)